Company dossier
Piramal Pharma
NSE:PPLPHARMA · ISIN INE0DK501011
- Close
- ₹195.68 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Piramal Pharma
Ownership
Shareholding pattern
Exchange XBRLOwnership by reported class
| Holder class | 30 Jun 26 | 31 Mar 26 | 31 Dec 25 | 30 Sept 25 | 30 Jun 25 | 31 Mar 25 |
|---|---|---|---|---|---|---|
| Promoter group | 34.80% | 34.86% | 34.86% | 34.86% | 34.86% | 34.95% |
| Public | 64.72% | 64.81% | 64.70% | 64.63% | 64.57% | 64.71% |
| Employee trust | 0.48% | 0.34% | 0.44% | 0.51% | 0.57% | 0.34% |
Next ownership layer
Planned enrichmentHolder-level detail
Mutual funds, foreign institutions, insurers, promoter entities, pledges and beneficial-owner changes will be added from detailed shareholding facts. This summary does not infer those classes.